Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
BioMarin Pharmaceuticals
Business Segments
Products & Services
Payment received as percentage of net product sales
Payment received as percentage of net product sales
BioMarin Pharmaceuticals
·
Products & Services
·
1 segment
Breakdown
Segments
ALDURAZYME
View metric
Quarterly
Annual
TTM
Segment
Q4 '23
Q4 '24
Q4 '25
ALDURAZYME
50%
50%
50%
Total
50%
50%
50%